HARROW HEALTH, INC. Purchase Agreements

28 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Purchase Agreement among Novartis Technology LLC, Novartis Innovative Therapies AG, and Harrow Health, Inc. (and Affiliates) dated December 13, 2022
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2022
Asset Purchase Agreement between Novartis Technology LLC, Novartis Ophthalmics AG, and Harrow Health, Inc. (December 17, 2021)
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2022
Basic Sale and Purchase Agreement between Wakamoto Pharmaceutical Co., Ltd. and Harrow Health, Inc.
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2021
Securities Purchase Agreement between Harrow Health, Inc. and B. Riley Securities, Inc. dated May 5, 2021
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2021
Asset Purchase Agreement between Noice Rx, LLC and Park Compounding, Inc. dated July 26, 2019
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2019
Asset Purchase Agreement dated February 1, 2019 between Harrow Health, Inc. and Elle Pharmaceuticals, Inc
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2019
Asset Purchase Agreement dated February 1, 2019 between Harrow Health, Inc. and Mayfield Pharmaceuticals, Inc
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2019
Asset Purchase Agreement dated December 11, 2018 between Imprimis Pharmaceuticals, Inc. and Melt Pharmaceuticals, Inc
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2019
Amended and Restated Asset Purchase and License Agreement between Imprimis Pharmaceuticals, Inc. and Surface Pharmaceuticals, Inc.
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2018
Asset Purchase and License Agreement between Imprimis Pharmaceuticals, Inc. and Surface Pharmaceuticals, Inc.
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2018
Asset Purchase Agreement between Imprimis Pharmaceuticals, Inc. and Creative Pharmacy Solutions Central, LLC (Pharmacy Innovations)
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
PA
2017
Asset Purchase and License Agreement between Imprimis Pharmaceuticals, Inc. and Eton Pharmaceuticals, Inc. dated May 9, 2017
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2017
Asset Purchase and License Agreement between Imprimis Pharmaceuticals, Inc. and Eton Pharmaceuticals, Inc.
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2017
Securities Purchase Agreement between Imprimis Pharmaceuticals, Inc. and Buyers Dated March 21, 2017
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2017
Stock Purchase Agreement between Imprimis Pharmaceuticals, Inc., ImprimisRx TX, Inc., and Livernois & London, LLC
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2017
Securities Purchase Agreement between Imprimis Pharmaceuticals, Inc. and Buyers (December 19, 2016)
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2016
Asset Purchase Agreement between Thousand Oaks Holding Company, Subsidiaries, and ImprimisRx PA, Inc.
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2015
Stock Purchase Agreement among Imprimis Pharmaceuticals, Inc., Jonathan Nguyen, Julie Trinh, and JT Pharmacy, Inc.
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
TX
2015
Asset Purchase Agreement between Novel Drug Solutions, LLC and Imprimis Pharmaceuticals, Inc.
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2014
Membership Interest Purchase Agreement among John Scott Karolchyk, Bernard Covalesky, and Imprimis Pharmaceuticals, Inc. dated February 10, 2014
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NJ
2014
Amendment to Asset Purchase Agreement among Novel Drug Solutions LLC, Eye Care Northwest, PA, and Imprimis Pharmaceuticals, Inc.
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2013
Asset Purchase Agreement between Novel Drug Solutions LLC, Eye Care Northwest, PA, and Imprimis Pharmaceuticals, Inc.
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2013
Asset Purchase Agreement between Buderer Drug Company, Inc. and Imprimis Pharmaceuticals, Inc. dated June 11, 2013
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2013
Securities Purchase Agreement between Imprimis Pharmaceuticals Inc. and Professional Compounding Centers of America, Inc. (August 30, 2012)
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2012
First Amended Securities Purchase Agreement between Transdel Pharmaceuticals, Inc. and DermaStar International, LLC
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2012
Securities Purchase Agreement between Imprimis Pharmaceuticals Inc. and Purchasers
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2012
Securities Purchase Agreement between Transdel Pharmaceuticals, Inc. and DermaStar International, LLC (November 21, 2011)
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2011
Asset Purchase Agreement among Transdel Pharmaceuticals, Inc., Cardium Healthcare, Inc., and Cardium Therapeutics Inc.
Purchase Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2011